Wellington Management Group
CPRX

Wellington Management Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Wellington Management Group’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-46,817
Closed -$1.16M – 1958
2026
Q1 		$1.16M Sell
46,817
-3,095
-6% -$73.7K ﹤0.01% 1648
2025
Q4 		$1.16M Sell
49,912
-3,066
-6% -$68.3K ﹤0.01% 1695
2025
Q3 		$1.04M Buy
52,978
+6,619
+14% +$136K ﹤0.01% 1770
2025
Q2 		$1.01M Sell
46,359
-2,088
-4% -$49.3K ﹤0.01% 1721
2025
Q1 		$1.17M Sell
48,447
-3,103
-6% -$69.9K ﹤0.01% 1669
2024
Q4 		$1.08M Sell
51,550
-8,034
-13% -$173K ﹤0.01% 1702
2024
Q3 		$1.18M Buy
+59,584
New +$1.1M ﹤0.01% 1677
2023
Q2 		– Sell
-121,575
Closed -$2.02M – 1840
2023
Q1 		$2.02M Buy
121,575
+9,211
+8% +$152K ﹤0.01% 1512
2022
Q4 		$2.09M Buy
112,364
+50,650
+82% +$780K ﹤0.01% 1504
2022
Q3 		$792K Sell
61,714
-108,696
-64% -$1.29M ﹤0.01% 1698
2022
Q2 		$1.19M Sell
170,410
-503
-0.3% -$3.69K ﹤0.01% 1646
2022
Q1 		$1.42M Sell
170,913
-3,301
-2% -$23.3K ﹤0.01% 1676
2021
Q4 		$1.18M Buy
+174,214
New +$1.15M ﹤0.01% 1774

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group's CPRX Position: Q2 2026 in Review

Wellington Management Group sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 46,817 shares — an estimated $1.16M sold.

Wellington Management Group first reported a position in CPRX in Q4 2021 and held it in 13 quarters. The position peaked at $2.09M in Q4 2022. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Wellington Management Group reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Wellington Management Group sold 46,817 Catalyst Pharmaceutical shares in Q2 2026, an estimated $1.16M.
  • Wellington Management Group first reported a position in Catalyst Pharmaceutical in Q4 2021 and held it in 13 quarters.
  • Wellington Management Group's Catalyst Pharmaceutical position peaked at $2.09M in Q4 2022.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.